Stock LPCN LIPOCINE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Lipocine Inc.

Equities

LPCN

US53630X2036

Delayed Nasdaq
Other stock markets
 11:15:24 2024-04-29 EDT 		5-day change 1st Jan Change
4.7 USD -2.04% Intraday chart for Lipocine Inc. -7.30% +68.46%
04-12 Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial MT
04-11 Top Premarket Gainers MT

Evolution of the average Target Price on Lipocine Inc.

Price target over the last 5 years

History of analyst recommendation changes

f6c9bbbf734ca601.j3FQqEazzmnAOybJCrEBraoAO3jEpe2yQlaTsdUkroM.uyUcwRzkuwejWFaGO9V22cFZbDyx6bT7ODSj2-1Wn-62MjTAKcGdJY9WUQ~01b2fe56ab700446eadfecc94fc52bf8

Analyst Recommendations on Lipocine Inc.

LIPOCINE : HC Wainwright Adjusts Lipocine's Price Target to $3.50 From $2.50, Keeps Buy Rating MT
LIPOCINE : Cantor Fitzgerald Starts Lipocine at Overweight With $3 Price Target MT
LIPOCINE : Ladenburg Thalmann Adjusts Lipocine's Price Target to $2.50 From $3, Maintains Buy Rating MT
LIPOCINE : HC Wainwright Adjusts Price Target for Lipocine to $2.50 From $3, Maintains Buy Rating MT
LIPOCINE : Ladenburg Thalmann Upgrades Lipocine to Buy From Neutral, $3 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.798 USD
Average target price
33 USD
Spread / Average Target
+587.83%
High Price Target
33 USD
Spread / Highest target
+587.83%
Low Price Target
33 USD
Spread / Lowest Target
+587.83%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Lipocine Inc.

HC Wainwright
Cantor Fitzgerald
Ladenburg Thalmann

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LPCN Stock
  4. Consensus Lipocine Inc.